DeepCell

DeepCell is an artificial intelligence company in San Francisco Bay Area, United States, founded in 2017. It has raised $20.0M across 1 round, most recently a $20.0M Series A in December 2020.

Where AI meets living cells

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M Series ADec 2020
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

DeepCell is a life sciences technology company that has developed the REM-I platform — an integrated system combining label-free imaging, deep learning AI, and gentle cell enrichment to analyze and sort living cells based on their morphology. The platform enables researchers and clinicians to profile single cells without fluorescent labels or destructive preparation, revealing high-dimensional biological insights invisible to conventional methods. Key application areas include oncology (tumor heterogeneity, rare cell sorting), drug discovery (phenotypic screening, mechanism of action), and cell and gene therapy (quality control, manufacturing). DeepCell is headquartered in Menlo Park, California.

Summary

It lists 51–200 employees. It has raised $20.0M in total across 1 round, most recently a $20.0M Series A round in Dec 2020. Investors include Bow Capital, Andreessen Horowitz and DCVC (Data Collab).

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2020
$20.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DeepCell on Indexed.vc
<a href="https://indexed.vc/companies/deepcell"><img src="https://indexed.vc/api/badge/company/deepcell" alt="DeepCell on Indexed.vc" width="260" height="76" /></a>